🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06149650
Active, not recruiting Observational

Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study

NCT06149650 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2024-07-15
Last updated
2026-07-30

Condition(s) studied

Chronic Limb-Threatening Ischemia

Investigational drug(s) / intervention(s)

Shockwave Medical IVL System

Shockwave Medical IVL System: Comprehensive system consisting of generator, a connector cable and a single-use sterile catheter with integrated balloon for intravascular lithotripsy of peripheral artery calcification.

Study summary

CALCIO is a multicentre, prospective, observational cohort study that will collect real world data on the use of intravascular Lithotripsy (IVL) with the Shockwave IVL system to disrupt calcified femoropopliteal and crural lesions in patients with chronic limb-threatening ischemia (CLTI). The primary objective of CALCIO is to understand the effectiveness of IVL in promoting wound healing and preventing amputation. The secondary objectives of CALCIO are to evaluate the immediate effectiveness of the treatment in restoring vessel patency as well as its safety and impact on patients' quality of life.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient with chronic limb-threatening ischemia (Rutherford Category ≥4) * Femoropopliteal and/or crural calcified lesions visible on fluoroscopy; * Treatment with IVl using the Shockwave Medical IVL System. Exclusion Criteria: * \< 18 years old; * Incapacity or refusal to give informed consent; * Ongoing pregnancy; * Endovascular procedure(s) on the treatment site within 4 weeks before the planned IVL treatment.

Primary outcome measure(s)

Trial sites (39)

FacilityCityRegionStatus
Krankenhaus der Barmherzigen Brüder Eisenstadt Austria
Medizinische Universität Graz Graz Austria
Krankenhaus Barmherzige Brüder Linz Linz Austria
Klinik Hietzing Vienna Austria
Klinik Florisdorf Vienna Austria
Hôpital Sacré Coeur de Montréal Montreal Canada
CHU François Mitterrand Dijon France
Institute Mutualiste Montsouris Paris France
Rhéna Clinique de Strasbourg Strasbourg France
Universitätsklinikum Köln Cologne Germany
Universitätsmedizin Essen Essen Germany
KRH Klinikum Robert Koch Gehrden Hanover Germany
SLK-Heilbronn Heilbronn Germany
Städtisches Klinikum Karlsruhe Germany
Evangelisches Krankenhaus Mülheim Germany
Friedrich Ebert Krankenhaus Neumünster Germany
Schön Klinik Rendsburg Rendsburg Germany
St Marien-Krankenhaus Siegen Germany
Universitätsklinikum Tübingen Tübingen Germany
Semmelweis University Budapest Hungary
Hospital General Universitario Dr. Balmis Alicante Spain
Hospital General de Granollers Granollers Spain
University of Navarra Pamplona Spain
Ente Ospedaliero Cantonale Lugano Switzerland
Kantonsspital Winterthur Winterthur Switzerland
Bedfordshire Hospitals NHS Foundation Trust Bedford United Kingdom
Frimley Health NHS Foundation Trust Frimley United Kingdom
Hull University Teaching Hospitals NHS Trust Hull United Kingdom
Leeds Teaching Hospitals NHS Trust Leeds United Kingdom
Liverpool University Hospitals NHS Foundation Trust Liverpool United Kingdom
University College London Hospitals NHS Foundation Trust London United Kingdom
Royal Free London NHS Foundation Trust London United Kingdom
St George's University Hospitals NHS Foundation Trust London United Kingdom
Imperial College Healthcare NHS Trust London United Kingdom
Manchester University NHS Foundation Trust Manchester United Kingdom
Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle United Kingdom
Oxford University Hospitals NHS Foundation Trust Oxford United Kingdom
University Hospitals Plymouth NHS Trust Plymouth United Kingdom
Sheffield Teaching Hospitals NHS FT Sheffield United Kingdom

More Cardiovascular and Interventional Radiological Society of Europe trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06149650 on ClinicalTrials.gov ↗ ← All trials in Germany